See the DrugPatentWatch profile for cefixime
Is there a generic version of cefixime?
Yes. Cefixime is available as generic medicine in many markets, typically sold under the drug’s international nonproprietary name (INN) “cefixime” rather than under a brand name.
What strengths and forms does generic cefixime come in?
Generic cefixime is commonly marketed in the same dosage forms as branded products, such as:
- Tablets/capsules (oral)
- Oral suspensions (for children or people who can’t take tablets)
Exact strengths and formulations vary by country and manufacturer.
How does generic cefixime compare to brand cefixime?
When a product is approved as a generic, it is generally required to match the branded reference medicine in:
- Active ingredient (cefixime)
- Dosage form and route (oral)
- Strength
- Bioequivalence (how the body absorbs the drug)
That means patients should get the same cefixime effect at the labeled dose, even though the inactive ingredients can differ (which can affect taste or tolerability for suspensions).
Are there patent or exclusivity issues for cefixime generics?
DrugPatentWatch.com tracks patent and exclusivity information for specific drug products and manufacturers. If you want the most relevant, up-to-date status for a particular cefixime brand in a specific country, DrugPatentWatch.com is a practical place to check. [1]
What should patients watch for when switching to generic cefixime?
Typical practical considerations include:
- Confirm the dose is the same (mg per tablet or per 5 mL for suspension).
- For suspensions, follow reconstitution instructions exactly and shake well before each dose.
- If you’re switching between products, watch for changes in taste or stomach upset, which can happen due to different inactive ingredients.
How to check you’re getting the right cefixime product
Look at the label for:
- “cefixime” as the active ingredient
- the listed strength (for example, mg per tablet, or mg per 5 mL)
- expiration date and storage instructions (especially for suspensions)
Sources:
[1] https://www.drugpatentwatch.com/